BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 25510661)

  • 1. Mitochondrial abnormalities and low grade inflammation are present in the skeletal muscle of a minority of patients with amyotrophic lateral sclerosis; an observational myopathology study.
    Al-Sarraj S; King A; Cleveland M; Pradat PF; Corse A; Rothstein JD; Leigh PN; Abila B; Bates S; Wurthner J; Meininger V
    Acta Neuropathol Commun; 2014 Dec; 2():165. PubMed ID: 25510661
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TDP-43 in skeletal muscle of patients affected with amyotrophic lateral sclerosis.
    Sorarú G; Orsetti V; Buratti E; Baralle F; Cima V; Volpe M; D'ascenzo C; Palmieri A; Koutsikos K; Pegoraro E; Angelini C
    Amyotroph Lateral Scler; 2010; 11(1-2):240-3. PubMed ID: 19306141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phosphorylated TDP-43 (pTDP-43) aggregates in the axial skeletal muscle of patients with sporadic and familial amyotrophic lateral sclerosis.
    Cykowski MD; Powell SZ; Appel JW; Arumanayagam AS; Rivera AL; Appel SH
    Acta Neuropathol Commun; 2018 Apr; 6(1):28. PubMed ID: 29653597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylated TDP-43 aggregates in skeletal and cardiac muscle are a marker of myogenic degeneration in amyotrophic lateral sclerosis and various conditions.
    Mori F; Tada M; Kon T; Miki Y; Tanji K; Kurotaki H; Tomiyama M; Ishihara T; Onodera O; Kakita A; Wakabayashi K
    Acta Neuropathol Commun; 2019 Oct; 7(1):165. PubMed ID: 31661037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients.
    Delic V; Kurien C; Cruz J; Zivkovic S; Barretta J; Thomson A; Hennessey D; Joseph J; Ehrhart J; Willing AE; Bradshaw P; Garbuzova-Davis S
    J Neurosci Res; 2018 Aug; 96(8):1353-1366. PubMed ID: 29732581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis.
    Crugnola V; Lamperti C; Lucchini V; Ronchi D; Peverelli L; Prelle A; Sciacco M; Bordoni A; Fassone E; Fortunato F; Corti S; Silani V; Bresolin N; Di Mauro S; Comi GP; Moggio M
    Arch Neurol; 2010 Jul; 67(7):849-54. PubMed ID: 20625092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscle histopathology in upper motor neuron-dominant amyotrophic lateral sclerosis.
    Sorarù G; D'Ascenzo C; Nicolao P; Volpe M; Martignago S; Palmieri A; Romeo V; Koutsikos K; Piccione F; Cima V; Pegoraro E; Angelini C
    Amyotroph Lateral Scler; 2008 Oct; 9(5):287-93. PubMed ID: 18608096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation of STIM1 is associated with the degenerative muscle fibre phenotype in ALS and other neurogenic atrophies.
    Goswami A; Jesse CM; Chandrasekar A; Bushuven E; Vollrath JT; Dreser A; Katona I; Beyer C; Johann S; Feller AC; Grond M; Wagner S; Nikolin S; Troost D; Weis J
    Neuropathol Appl Neurobiol; 2015 Apr; 41(3):304-18. PubMed ID: 24957221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
    Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
    Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sporadic amyotrophic lateral sclerosis (SALS) - skeletal muscle response to cerebrospinal fluid from SALS patients in a rat model.
    Shanmukha S; Narayanappa G; Nalini A; Alladi PA; Raju TR
    Dis Model Mech; 2018 Apr; 11(4):. PubMed ID: 29666144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The RNA-binding motif 45 (RBM45) protein accumulates in inclusion bodies in amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration with TDP-43 inclusions (FTLD-TDP) patients.
    Collins M; Riascos D; Kovalik T; An J; Krupa K; Krupa K; Hood BL; Conrads TP; Renton AE; Traynor BJ; Bowser R
    Acta Neuropathol; 2012 Nov; 124(5):717-32. PubMed ID: 22993125
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptide repeat protein inclusions are rare in the spinal cord and almost absent from motor neurons in C9ORF72 mutant amyotrophic lateral sclerosis and are unlikely to cause their degeneration.
    Gomez-Deza J; Lee YB; Troakes C; Nolan M; Al-Sarraj S; Gallo JM; Shaw CE
    Acta Neuropathol Commun; 2015 Jun; 3():38. PubMed ID: 26108573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyotrophic lateral sclerosis: dash-like accumulation of phosphorylated TDP-43 in somatodendritic and axonal compartments of somatomotor neurons of the lower brainstem and spinal cord.
    Braak H; Ludolph A; Thal DR; Del Tredici K
    Acta Neuropathol; 2010 Jul; 120(1):67-74. PubMed ID: 20379728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
    Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
    Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence of multisystem disorder in whole-brain map of pathological TDP-43 in amyotrophic lateral sclerosis.
    Geser F; Brandmeir NJ; Kwong LK; Martinez-Lage M; Elman L; McCluskey L; Xie SX; Lee VM; Trojanowski JQ
    Arch Neurol; 2008 May; 65(5):636-41. PubMed ID: 18474740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCBP2 Is Downregulated in Degenerating Neurons and Rarely Observed in TDP-43-Positive Inclusions in Sporadic Amyotrophic Lateral Sclerosis.
    Yoshimura M; Honda H; Sasagasako N; Mori S; Hamasaki H; Suzuki SO; Ishii T; Ninomiya T; Kira JI; Iwaki T
    J Neuropathol Exp Neurol; 2021 Feb; 80(3):220-228. PubMed ID: 33313661
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional recovery in new mouse models of ALS/FTLD after clearance of pathological cytoplasmic TDP-43.
    Walker AK; Spiller KJ; Ge G; Zheng A; Xu Y; Zhou M; Tripathy K; Kwong LK; Trojanowski JQ; Lee VM
    Acta Neuropathol; 2015 Nov; 130(5):643-60. PubMed ID: 26197969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexistence of Huntington's disease and amyotrophic lateral sclerosis: a clinicopathologic study.
    Tada M; Coon EA; Osmand AP; Kirby PA; Martin W; Wieler M; Shiga A; Shirasaki H; Tada M; Makifuchi T; Yamada M; Kakita A; Nishizawa M; Takahashi H; Paulson HL
    Acta Neuropathol; 2012 Nov; 124(5):749-60. PubMed ID: 22735976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased cystatin C immunoreactivity in spinal motor neurons and astrocytes in amyotrophic lateral sclerosis.
    Mori F; Tanji K; Miki Y; Wakabayashi K
    J Neuropathol Exp Neurol; 2009 Nov; 68(11):1200-6. PubMed ID: 19816197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.